Aspira Pathlab & Diagnostics Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Aspira Pathlab & Diagnostics has a total shareholder equity of ₹101.4M and total debt of ₹27.8M, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are ₹147.1M and ₹45.7M respectively.
Belangrijke informatie
27.4%
Verhouding schuld/eigen vermogen
₹27.82m
Schuld
| Rente dekkingsratio | n/a |
| Contant | ₹13.84m |
| Aandelen | ₹101.43m |
| Totaal verplichtingen | ₹45.66m |
| Totaal activa | ₹147.10m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 540788's short term assets (₹43.6M) exceed its short term liabilities (₹20.7M).
Langlopende schulden: 540788's short term assets (₹43.6M) exceed its long term liabilities (₹25.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 540788's net debt to equity ratio (13.8%) is considered satisfactory.
Schuld verminderen: 540788's debt to equity ratio has reduced from 130% to 27.4% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Whilst unprofitable 540788 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Voorspelling contante baan: 540788 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34% per year.